Why Chemours Plunged Today

Core Insights - Chemours' shares fell 16.8% following the release of disappointing earnings and guidance that only met analyst expectations [1] - The company reported a 2.2% revenue decline in Q4, with adjusted earnings per share dropping 46% to $0.05, missing expectations by $0.02 [2] - For the upcoming year, Chemours forecasts revenue growth of 3% to 5%, projecting revenues between $5.98 billion and $6.10 billion for 2026 [3] Financial Performance - The adjusted EBITDA is expected to be between $800 million and $900 million, indicating a 14.6% increase at the midpoint compared to 2025's EBITDA of $742 million [3] - The 2025 EBITDA was impacted by a one-time inventory charge in the Advanced Performance Materials segment, which is facing short-term cyclical headwinds [4] Growth Opportunities - Chemours' Opteon low-carbon refrigerants segment showed significant growth, with a 56% increase last year, contributing to a 13% growth in the Thermal Solutions segment [8] - Opteon sales accounted for 22% of Chemours' total sales last year, suggesting potential for further growth if other segments recover [8]